VEKLURY® (REMDESIVIR) FORMULATIONS INHIBIT INITIAL MEMBRANE-COUPLED EVENTS OF SARS-COV-2 INFECTION DUE TO THEIR CYCLODEXTRIN CONTENT
| dc.contributor.author | Kurtán Kitti | |
| dc.contributor.author | Dr. Kovács Tamás | |
| dc.contributor.author | Dr. Zákány Florina | |
| dc.contributor.department | Általános Orvostudományi Kar | hu |
| dc.date.accessioned | 2023-12-13T17:56:31Z | |
| dc.date.available | 2023-12-13T17:56:31Z | |
| dc.date.issued | 2023-12 | |
| dc.identifier.uri | https://hdl.handle.net/2437/362307 | |
| dc.title | VEKLURY® (REMDESIVIR) FORMULATIONS INHIBIT INITIAL MEMBRANE-COUPLED EVENTS OF SARS-COV-2 INFECTION DUE TO THEIR CYCLODEXTRIN CONTENT |